Key Financial Outcomes

Tata Chemicals delivered another strong set of numbers during FY 2022-23, with Revenue up by ₹ 4,167 Crore and EBITDA by ₹ 1,517 Crore as we channeled the benefit of improved realisations, while progressing steadfastly on our strategic trajectory. Our focus on serving customers further aided us in driving growth, as we continued to invest in being their partner of choice.

Our growth is an outcome of our sustained focus on sharpening our core competencies. At the same time, it is driven by our continuous efforts to nurture the business by being responsible corporate citizens and delivering greater value to our stakeholders. We believe our strengths and efforts are together helping us ensure sustainable growth. They are also concurrently enabling us to work with our stakeholder groups to deliver on our objective of a sustainable future.

Revenues(₹in Crore)
EBITDA and
EBITDA margin
PBT and
PBT margin
PAT and
PAT margin

Note: PAT is for Continuing Operations only

Cash from Operations(₹in Crore)
Net Debt : Equity
Net Debt : EBITDA
Market Capitalisation(₹in Crore)

Market Capitalisation based on
Closing Price as on March 31

Dividend Per Share(₹)

CFO on Performance Review

All our financial metrics improved in FY 2022-23, with increase in margins, leading to our balance sheet getting further strengthened. Our cash generation was robust and we started prepaying our debts across all geographies. Overall, a robust financial performance.

Nandakumar S. Tirumalai Chief Financial Officer